We sit back and watch the share price be hammered and does any one buy considering the raising dilutionary aspect.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game